Medical Condition News

RSS

Xience V stent performs well in patients with primary PCI for ST elevation myocardial infarction

The second generation drug-eluting stent Xience V performs well in patients having primary PCI for ST elevation myocardial infarction, and has a better safety profile than that of bare metal stents, according to results of the EXAMINATION trial.

30 Aug 2011

AstraZeneca: BRILIQUE receives Class I recommendation from ESC

AstraZeneca today announced BRILIQUE, a new oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised "Guidelines for Management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation."

30 Aug 2011

Results of darexaban phase II trial in recent acute coronary syndrome presented at ESC Congress

A phase II dose-finding study has found that the new oral Factor Xa inhibitor darexaban was associated with a two to four-fold increase in bleeding when added to dual antiplatelet therapy in patients following an acute coronary syndrome.

30 Aug 2011

Intra-aortic balloon counterpulsation prior to PCI does not reduce infarct size in AMI patients

Inserting intra-aortic balloon pumps prior to angioplasty in patients with acute myocardial infarction (AMI) does not reduce the scope of heart muscle damage, a condition referred to as infarct size, according to a new study conducted by Duke University Medical Center researchers.

30 Aug 2011

An advance toward using stem cells in 'regenerative medicine'

With stem cells so fickle and indecisive that they make Shakespeare's Hamlet pale by comparison, scientists today described an advance in encouraging stem cells to make decisions about their fate.

30 Aug 2011

Educational program about cardiovascular prevention in children can reduce parents' CVD risk

"A multidisciplinary educational programme in cardiovascular prevention directed to children of school age can reduce their parents' cardiovascular risk. Cardiovascular prevention could have more success focusing on children first, inducing healthier lifestyle habits in the whole family, "said investigator Luciana Fornari, from the University of Sao Paulo, Brazil.

30 Aug 2011

Everolimus-eluting stent reduces incidence of stent thrombosis

Results of the independently-funded Bern-Rotterdam cohort study provide robust evidence of an "important" reduction in overall and very late stent thrombosis.

30 Aug 2011

Remote follow-up of ICD patients seems to be a safe alternative to conventional in-office methods

Results from the EVATEL trial are the first in Europe to demonstrate potential safety and efficacy benefits from the remote follow-up of ICD patients.

30 Aug 2011

Ipsen, Inspiration partner to launch hemophilia product portfolio in Europe

Ipsen and Inspiration Biopharmaceuticals Inc. today announced they have entered into a strategic partnership agreement, to create a European hemophilia commercial organization, to launch Inspiration's hemophilia product portfolio in Europe.

30 Aug 2011

St. John Hospital enrolls first patient in Moxy- Drug Coated Balloon trial for PAD

Physicians at St. John Hospital and Medical Center have enrolled the first patient in Michigan in LEVANT2, a global, multicenter, randomized clinical trial evaluating the safety and effectiveness of the Moxy- Drug Coated Balloon for the treatment of peripheral arterial disease.

30 Aug 2011

AAN calls on all neurology patients, caregivers to participate in 2012 Neuro Film Festival

The American Academy of Neurology Foundation is calling on all neurology patients and caregivers to submit a short video to its 2012 Neuro Film Festival, telling their story about why more research is needed into finding cures for brain disorders.

30 Aug 2011

New chemical compounds show promise against set of protein-folding diseases

Collaborating researchers at Stanford University and The Scripps Research Institute have identified chemical compounds that show promise as potential therapeutics for a set of medical conditions caused by the abnormal clumping together of a protein known as transthyretin.

30 Aug 2011

Medical Condition News

Xience V stent performs well in patients with primary PCI for ST elevation myocardial infarction

AstraZeneca: BRILIQUE receives Class I recommendation from ESC

Results of darexaban phase II trial in recent acute coronary syndrome presented at ESC Congress

Intra-aortic balloon counterpulsation prior to PCI does not reduce infarct size in AMI patients

An advance toward using stem cells in 'regenerative medicine'

Educational program about cardiovascular prevention in children can reduce parents' CVD risk

Everolimus-eluting stent reduces incidence of stent thrombosis

Remote follow-up of ICD patients seems to be a safe alternative to conventional in-office methods

Ipsen, Inspiration partner to launch hemophilia product portfolio in Europe

St. John Hospital enrolls first patient in Moxy- Drug Coated Balloon trial for PAD

AAN calls on all neurology patients, caregivers to participate in 2012 Neuro Film Festival

New chemical compounds show promise against set of protein-folding diseases

Study indicates large gap in use of proven therapies for heart attack or stroke

Study: Social partners can help extend memory

Researchers demonstrate benefits of 8-week 'Beating Heart Problems' group programme

Study finds higher incidence of arrhythmias in elite cross-country skiers

Researchers investigate potential of vesicular stomatitis virus against soft tissue sarcomas

UCLA program helps improve seniors' self-perceived memory

Clinical trial to evaluate RMN system for treatment of ischemic Ventricular Tachycardia

St. Michael's Echocardiography and Vascular Laboratory receives ICAEL accreditation

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News